Article

The Effect of Bone-Modifying Agents on Post-Bone Metastasis Survival

2024-12-11

Abstract excerpt

<h4>Background: </h4> Bone metastasis is associated with a poor prognosis. Bone-modifying agents (BMA) are commonly used for the prevention or treatment of skeletal-related events (SRE) in patients with bone metastasis; however, whether or not treatment with BMA improves survival remains unclear. In this study, we investigated whether BMA was involved in post-bone metastasis survival. <h4>Methods:</h4> A total of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b169b668-6d3d-5af4-bdf8-5826058cc5c1
DOI: 10.20944/preprints202412.0954.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Effect of Bone-Modifying Agents on Post-Bone Metastasis SurvivalDOI 10.20944/preprints202412.0954.v1Read

Prognosis of different bone metastases patterns in EGFR-mutant advanced lung adenocarcinoma patientsSemantic proximity Read

Prognostic Risk Factors for Cancer-Specific Bone Metastasis: A Registry-Based Analysis of 13,742 PatientsSemantic proximity Read

Assessing EGFR-mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy.Semantic proximity Read

Prognostic Factors in Lung Adenocarcinoma with Bone Metastasis Treated with EGFR-TKIs.Semantic proximity Read

[Impact of bone metastasis on the prognosis of lung adenocarcinoma patients treated with third-generation EGFR-TKI and the underlying mechanisms].Semantic proximity Read

Invasion and metastasis in cancer: molecular insights and therapeutic targetsSemantic proximity Read

Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter studySemantic proximity Read

Clinical Implications of Isolated Bone Failure Without Systemic Disease Progression During EGFR-TKI Treatment.Semantic proximity Read

Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancerSemantic proximity Read

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.Semantic proximity Read

Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.Semantic proximity Read

Clinical features and KRAS mutation in colorectal cancer with bone metastasis.Semantic proximity Read